StockData
GT Biopharma, Inc. logo

GT Biopharma, Inc. (GTBP) stock

GTBPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 5/30
$3.18−0.35 (-10.04%)

Close on Nov 17, 2026Market cap $143.45MP/E –Yield –

GT Biopharma operating margin

Operating margin is operating income as a percentage of revenue.

For fiscal 2015 it was -33063.0%, against -3927.9% the year before. The highest annual figure on record is -215.5% in fiscal 2013.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2015Dec 31, 2015-33063.0%−29135.1
FY2014Dec 31, 2014-3927.9%−3712.4
FY2013Dec 31, 2013-215.5%+812.0
FY2012Dec 31, 2012-1027.5%+14080.2
FY2011Dec 31, 2011-15107.7%+7592.3
FY2010Dec 31, 2010-22700.0%–

More GT Biopharma figures

See a number that looks wrong?